Centricity Vision Appoints Jim Mazzo to its Board of Directors
October 1, 2020
Centricity Vision, Inc., a global ophthalmic technology company dedicated to delivering solutions that help surgeons achieve surgical and clinical excellence, today announced that Jim Mazzo has been appointed to the company’s Board of Directors. Mazzo is one of the ophthalmic industry’s best known and most well respected business leaders with over 40 years of proven experience.
“I am excited to join Centricity Vision’s Board of Directors and look forward to working with this exceptional team to increase global access to the ZEPTO Platform,” said Mazzo.
OIS Podcast: Listening to the Needs of the Customer from Centricity Vision’s Rob Thornhill
September 18, 2020
Dr. Ehsan Sadri and Rob Thornhill discuss the benefits of the Zepto Precision Cataract Surgery device in delivering automated, precise, circular, and centered capsulotomies - how their business model evolved during COVID-19 and the future direction for the company.
Mynosys Changes Name to Centricity Vision and Names New Leadership Team
May 28, 2020
Centricity Vision, Inc., formerly known as Mynosys Cellular Devices, Inc., a global ophthalmic technology company dedicated to delivering products that help surgeons optimize outcomes in refractive surgery, today announced a new executive leadership team, along with a new company name.
How to Center Capsulotomy in Cataract Surgery (Healio)
April 21, 2020
At Hawaiian Eye 2020 in Koloa, Hawaii; Vance Thompson, MD, discusses the use of ZEPTO® automated capsulotomy in centering cataract surgery on the visual axis using Purkinje images.
EyeWorld Asia Pacific – “Capsulotomy Creation: Searching for Perfection”
March 2, 2020
Rich Daly, EyeWorld Contributing Writer reviews Dr. Uday Devgan’s and Dr. Larry Patterson’s various approaches to capsulotomy creation discussing ZEPTO® as one of the methods. Dr. Chee Soon Phaik, MD (Singapore) provides her approach to capsulotomy highlighting the benefits of ZEPTO®.
Mynosys Cellular Devices, Inc. Secures $25 Million Investment From Decheng Capital; Names Veteran Ophthalmic Executive Rob Thornhill as CEO
November 9, 2019
Mynosys Cellular Devices, Inc., manufacturer of the Zepto® cataract surgery device, today announced it finalized a $25 million financing round, led by Decheng Capital, and named veteran ophthalmology industry executive Rob Thornhill as Chief Executive Officer.
Precision pulse capsulotomy in challenging cataract surgery cases
July 29, 2019
A new case study using the Zepto® Precision Cataract Surgery system was published on July 25, 2019 in Clinical Ophthalmology: "Precision pulse capsulotomy in challenging cataract surgery cases.
Dr. Vance Thompson Interviewed at OSN Italy 2019 (Healio)
May 28, 2019
At the OSN Italy meeting, Dr. Vance Thompson gave the Benedetto Strampelli Medal Lecture. He discussed how to use the Purkinje images for centration, and performing a capsulotomy manually or with various technologies, including using Zepto®.